Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Choosing the right retirement account at 30 can be challenging. Learn about the different options available to make the best choice for your future.
22,749 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
When markets wobble, patient investors can uncover excellent stocks at better prices. This guide highlights two solid...
With AMD’s rally making headlines, a slate of overlooked names could ride the AI and defense cycle higher. Here are f...
A fresh look at AI investing shows the most dramatic gains might come from broad market value and international stock...
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
A modest insider sale can spark questions, but the bigger signal for investors is a company delivering solid earnings...
Taiwan Semiconductor Manufacturing Co. reports a 36% quarterly sales increase, with June revenue surging as memory eq...
As crypto markets face renewed volatility, USDT and USDC remain the two dominant stablecoins. This article weighs res...
SoundHound AI aims to own the voice layer that connects users to services. This article builds a practical bull case ...
Amazon's latest update from AWS leadership sparked a fresh investor conversation. This article breaks down what happe...
As Deere (DE) releases its 2026 earnings outlook, investors weigh crop cycles, equipment demand, and margin trends. T...
When a major tariff ruling shifts import costs, retail stocks can respond quickly. This article breaks down why these...